Literature DB >> 15150328

Transfer of specific antibodies results in increased expression of TNF-alpha and IL12 and recruitment of neutrophils to the site of a cutaneous Francisella tularensis infection.

Stephan Stenmark1, Anders Sjöstedt1.   

Abstract

This study demonstrates that passive transfer of Francisella tularensis-specific antibodies before experimental cutaneous infection with the live vaccine strain of F. tularensis has profound effects. Recipient mice showed stronger staining for TNF-alpha and IL12, and larger numbers of neutrophils in skin samples after infection than control mice.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15150328     DOI: 10.1099/jmm.0.05352-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  5 in total

1.  Francisella tularensis infection-derived monoclonal antibodies provide detection, protection, and therapy.

Authors:  Anne G Savitt; Patricio Mena-Taboada; Gloria Monsalve; Jorge L Benach
Journal:  Clin Vaccine Immunol       Date:  2009-01-28

2.  Role of primary human alveolar epithelial cells in host defense against Francisella tularensis infection.

Authors:  Megan Gentry; Joanna Taormina; Richard B Pyles; Linsey Yeager; Michelle Kirtley; Vsevolod L Popov; Gary Klimpel; Tonyia Eaves-Pyles
Journal:  Infect Immun       Date:  2007-05-14       Impact factor: 3.441

3.  Intranasal immunization with an archaeal lipid mucosal vaccine adjuvant and delivery formulation protects against a respiratory pathogen challenge.

Authors:  Girishchandra B Patel; Hongyan Zhou; Amalia Ponce; Greg Harris; Wangxue Chen
Journal:  PLoS One       Date:  2010-12-29       Impact factor: 3.240

Review 4.  Monocyte/macrophage inflammatory response pathways to combat Francisella infection: possible therapeutic targets?

Authors:  Devyn D Gillette; Susheela Tridandapani; Jonathan P Butchar
Journal:  Front Cell Infect Microbiol       Date:  2014-02-21       Impact factor: 5.293

Review 5.  Immunotherapy for tularemia.

Authors:  Jerod A Skyberg
Journal:  Virulence       Date:  2013-06-19       Impact factor: 5.882

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.